HOW FREQUENT IS CORTICOSTEROID-INDUCED GLAUCOMA? HOW SHOULD I MANAGE IT?

We have known for almost half a century that the use of both systemic and ocular corticosteroids can lead to an elevation of intraocular pressure (IOP). The IOP elevation is related to the type of corticosteroid and concentration, as well as route, frequency, and duration of administration. Usually, we are unable to stop corticosteroid treatment for a condition that is vision threatening. This chapter discusses the mechanism of IOP elevation, dose relationship between IOP elevation and corticosteroids, time course of response, risk factors, patient monitoring strategies, and treatment recommendations.